Biochemistry

  1. The Mechanism of SARS-CoV-2 Nucleocapsid Protein Recognition by the Human 14-3-3 Proteins

    1. Kristina V. Tugaeva
    2. Dorothy E.D.P. Hawkins
    3. Jake L.R. Smith
    4. Oliver W. Bayfield
    5. De-Sheng Ker
    6. Andrey A. Sysoev
    7. Oleg I. Klychnikov
    8. Alfred A. Antson
    9. Nikolai N. Sluchanko

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Characterization of SARS-CoV-2 nucleocapsid protein reveals multiple functional consequences of the C-terminal domain

    1. Chao Wu
    2. Abraham J. Qavi
    3. Asmaa Hachim
    4. Niloufar Kavian
    5. Aidan R. Cole
    6. Austin B. Moyle
    7. Nicole D. Wagner
    8. Joyce Sweeney-Gibbons
    9. Henry W. Rohrs
    10. Michael L. Gross
    11. J. S. Malik Peiris
    12. Christopher F. Basler
    13. Christopher W. Farnsworth
    14. Sophie A. Valkenburg
    15. Gaya K. Amarasinghe
    16. Daisy W. Leung

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  3. A High-Throughput RNA Displacement Assay for Screening SARS-CoV-2 nsp10-nsp16 Complex toward Developing Therapeutics for COVID-19

    1. Sumera Perveen
    2. Aliakbar Khalili Yazdi
    3. Kanchan Devkota
    4. Fengling Li
    5. Pegah Ghiabi
    6. Taraneh Hajian
    7. Peter Loppnau
    8. Albina Bolotokova
    9. Masoud Vedadi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Analysis of SARS-CoV-2 spike glycosylation reveals shedding of a vaccine candidate

    1. Juliane Brun
    2. Snežana Vasiljevic
    3. Bevin Gangadharan
    4. Mario Hensen
    5. Anu V. Chandran
    6. Michelle L. Hill
    7. J.L. Kiappes
    8. Raymond A. Dwek
    9. Dominic S. Alonzi
    10. Weston B. Struwe
    11. Nicole Zitzmann

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2

    1. Nadezhda V. Antipova
    2. Tatyana D. Larionova
    3. Andrei E. Siniavin
    4. Maria A. Nikiforova
    5. Vladimir A. Gushchin
    6. Igor I. Babichenko
    7. Alexey V. Volkov
    8. Michail I. Shakhparonov
    9. Marat S. Pavlyukov

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Ipomoeassin-F inhibits the in vitro biogenesis of the SARS-CoV-2 spike protein and its host cell membrane receptor

    1. Sarah O'Keefe
    2. Peristera Roboti
    3. Kwabena B. Duah
    4. Guanghui Zong
    5. Hayden Schneider
    6. Wei Q. Shi
    7. Stephen High

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Designed proteins assemble antibodies into modular nanocages

    1. Robby Divine
    2. Ha V. Dang
    3. George Ueda
    4. Jorge A. Fallas
    5. Ivan Vulovic
    6. William Sheffler
    7. Shally Saini
    8. Yan Ting Zhao
    9. Infencia Xavier Raj
    10. Peter A. Morawski
    11. Madeleine F. Jennewein
    12. Leah J. Homad
    13. Yu-Hsin Wan
    14. Marti R. Tooley
    15. Franziska Seeger
    16. Ali Etemadi
    17. Mitchell L. Fahning
    18. James Lazarovits
    19. Alex Roederer
    20. Alexandra C. Walls
    21. Lance Stewart
    22. Mohammadali Mazloomi
    23. Neil P. King
    24. Daniel J. Campbell
    25. Andrew T. McGuire
    26. Leonidas Stamatatos
    27. Hannele Ruohola-Baker
    28. Julie Mathieu
    29. David Veesler
    30. David Baker

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. High-level expression of the monomeric SARS-CoV-2 S protein RBD 320-537 in stably transfected CHO cells by the EEF1A1-based plasmid vector

    1. Maria V. Sinegubova
    2. Nadezhda A. Orlova
    3. Sergey V. Kovnir
    4. Lutsia K. Dayanova
    5. Ivan I. Vorobiev

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Cyclic 68 Ga-Labeled Peptides for Specific Detection of Human Angiotensin-Converting Enzyme 2

    1. Matthew F.L. Parker
    2. Joseph Blecha
    3. Oren Rosenberg
    4. Michael Ohliger
    5. Robert R. Flavell
    6. David M. Wilson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Proteoforms of the SARS-CoV-2 nucleocapsid protein are primed to proliferate the virus and attenuate the antibody response

    1. Corinne A. Lutomski
    2. Tarick J. El-Baba
    3. Jani R. Bolla
    4. Carol V. Robinson

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 73 of 93 Next